Buscar resultados de ensayos clínicos

Patrocinado por

Polycystic Kidney Diseases - 18 Studies Found

Estado Estudiar
Completed Nombre del estudio: Polycystic Kidney Disease Data Repository
Condición: Polycystic Kidney Disease
Fecha: 2008-11-14
Withdrawn Nombre del estudio: Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2013-11-07
Completed Nombre del estudio: Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condición: Polycystic Kidney Disease
Fecha: 2014-05-14
Intervenciones: Dietary Supplement: Niacinamide Other Name: Vitamin B3
Completed Nombre del estudio: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condición: Polycystic Kidney Diseases
Fecha: 2006-02-01
Intervenciones: Drug: Rapamune Group 1- doses of Rapamune aimed at maintaining trough levels 5-8ng/ml Group 2 - doses of
Completed Nombre del estudio: Lanreotide In Polycystic Kidney Disease Study
Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Fecha: 2014-04-02
Intervenciones:
  • Drug: Lanreotide 120 mg, subcu
Completed Nombre del estudio: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2007-12-31
Intervenciones: Drug: Tetracosactin 1 microgram tetracosactin, intravenous injection, once for the test
Enrolling by invitation Nombre del estudio: Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2009-12-23
Completed Nombre del estudio: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2011-10-11
Intervenciones:
  • Drug: Tolvaptan MR 50/80 mg ca
Completed Nombre del estudio: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2006-12-20
Intervenciones:
  • Drug: Placebo placebo comparat
Active, not recruiting Nombre del estudio: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2011-06-20
Intervenciones:
  • Drug: Octreotide-LAR 40 mg eve
Next >>>